Grants and Contributions:

Back to search

Title:

RNA COVID-19 Vaccine Project

Agreement Number:

513318

Agreement Value:

$10,318,654.00

Agreement Date:

Apr 28, 2020 - Mar 26, 2026

Description:

This project aimed to help advance the development of a COVID-19 vaccine candidate through pre-clinical studies and clinical trials.

Organization:

Innovation, Science and Economic Development Canada

Expected Results:

The vaccine project was to allow PNU to advance a made-in-Canada vaccine candidate.

Location:

Vancouver, British Columbia, CA V6P6T7

Reference Number:

033-2020-2021-Q3-513318

Agreement Type:

Contribution

Report Type:

Grants and Contributions

Recipient Business Number:

851285114

Recipient Type:

For-profit organization

Additional Information:

The amendment has been completed to terminate the contribution agreement by mutual consent.

Amendment Date

Mar 26, 2024

Recipient's Operating Name:

Precision NanoSystems ULC

Recipient's Legal Name:

Precision NanoSystems ULC

Federal Riding Name:

Vancouver Granville

Federal Riding Number:

59036

Program:

SIF Stream 1- R&D

Program Purpose:

-Encourage R&D that will accelerate technology transfer and commercialization of innovative products, processes and services;-Facilitate the growth and expansion of firms in Canada;-Attract and retain large scale investments to Canada; and-Advance industrial research, development and technology demonstration through collaboration between academia, non-profit organizations and the private sector.

NAICS Code:

541710

Amendments:

See Amendments